Тезепелумаб Астразенека

Tezspire (tezepelumab) approved in the European...

AstraZeneca shares tumble 15% on big drug trial...

Amgen, AstraZeneca's tezepelumab is looking for...

Relief for AZ, Amgen as FDA okays severe asthma...

ДЭМБ “Астразенека” компанийн вакцинаар дархлааж...

Long-term safety and efficacy of tezepelumab in...

Купить Тецентрик (Атезолизумаб) - Tecentriq (At...

Tezepelumab Benefits Asthma Patients Year-Round...

What is Tezepelumab? Side Effects, Benefits, an...

Tezepelumab Could Help Amgen Develop Its Inflam...

Figure 2 from Efficacy and Potential Positionin...

TEZSPIRE® (tezepelumab-ekko) HCP on LinkedIn: D...

AstraZeneca buys US lung drug firm Pearl Therap...

AstraZeneca (AZN) Investor Presentation - Slide...

By IPP Bureau | June 22, 2024

Two key AstraZeneca medicines accepted for use ...

Tezepelumab Shows Potential for COPD, Negative ...

(PDF) [Tezepelumab: a new option for the treatm...

US FDA grants priority review to tezepelumab to...

AstraZeneca severe asthma treatment Tezspire ge...

By IPP Bureau | September 10, 2024

AstraZeneca Welcomes Neurofibromatosis And Asth...

US FDA approves Amgen-AstraZeneca’s Tezspire fo...

(PDF) Tezepelumab as an Emerging Therapeutic Op...

FDA grants priority review to BLA for AstraZene...

Amgen, AstraZeneca's tezepelumab hits goal in a...

АстраЗенека вакцины хоёр дахь тунг энэ сарын 15...

AstraZeneca to acquire TeneoTwo and its clinica...

AstraZeneca Truqap plus Faslodex recommended fo...

Is Tezepelumab approved by the FDA?

FDA Approves Tezepelumab for Self-Administratio...

Tezepelumab in patients with allergic and eosin...

Tezepelumab Effective in Severe Asthma Cohorts ...

Japan Archives - Clinical Trials Arena

Tezepelumab Regulatory Submission Accepted and ...